TrialInternational journal of environmental research and public health2020

Comparing Paclitaxel-Carboplatin with Paclitaxel-Cisplatin as the Front-Line Chemotherapy for Patients with FIGO IIIC Serous-Type Tubo-Ovarian Cancer.

Chen-Yu Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.